Knowledge Hub

Treatment of vaccine-preventable disease carries a heavy financial toll for national health systems

Researchers estimate that vaccinating against 10 diseases in the world’s 94 poorest countries between 2011-2020 will avert US$586 billion in costs of illness (including treatment costs, transportation costs, lost caretaker wages and productivity losses due to death and disability). The 73 Gavi-supported countries account for US$544 billion of the treatment costs averted.

Full Citation:
Ozawa, S., Portnoy, A., Grewal, S., et al. 2016. Return on investment from childhood immunization in low- and middle-income countries, 2011-2020. Health Affairs. 35(2).

Title of Article: Return on investment from childhood immunization in low- and middle-income countries, 2011-2020

Author(s): Ozawa, S., Portnoy, A., Grewal, S., et al

Publication Year: 2016

Publication Name: Health Affairs

Publication Volume: 35(2)

Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/?term=26858370

DOI (Digital Object Identifier): 10.1377/hlthaff.2015.1086